$11.225
-0.135[-1.19%]
Last update: 11:12AM Get Real Time Here
Viatris
(NASDAQ:VTRS)Latest News for Viatris Stock (NASDAQ:VTRS)
Viatris Stock (NASDAQ: VTRS)
Categories: All
Thursday, May 09, 2024
- Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual ForecastVandana Singh - 4 days ago
- Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday?Piero Cingari - 4 days ago
- Viatris shares are trading lower after the company reported worse-than-expected Q1 sales results.Benzinga Newsdesk - 5 days ago
- Viatris Expects 2024 Adjusted EPS Of $2.66-$2.81 Versus Prior Guidance Of $2.70-$2.85 And Consensus Of $2.74Benzinga Newsdesk - 5 days ago
- Viatris Expects 2024 Revenues Of $14.98B-$15.48B Versus Consensus Of $15.19B And Prior Guidance Of $15.25B-$15.75BBenzinga Newsdesk - 5 days ago
- Viatris Q1 2024 GAAP EPS $0.67, Inline, Sales $3.663B Miss $3.691B EstimateBenzinga Newsdesk - 5 days ago
Wednesday, May 01, 2024
Monday, April 15, 2024
Monday, April 01, 2024
- Ocuphire Announces the US Commercial Launch of RYZUMVl (Phentolamine Ophthalmic Solution 0.75%) by its Partner ViatrisBenzinga Newsdesk - Apr 1, 2024, 7:17AM
- Viatris Announced The U.S. Commercial Launch Of Ryzumvi (Phentolamine Ophthalmic Solution) 0.75% For Pharmacologically-induced Mydriasis. Ryzumvi Is Now The Only U.S. Commercially Available FDA-approved Eye Drop To Reverse DilationBenzinga Newsdesk - Apr 1, 2024, 7:00AM
Thursday, March 28, 2024
Friday, March 15, 2024
Monday, March 11, 2024
- Viatris shares are trading lower after the company and Mapi Pharma received a Complete Response Letter from the FDA regarding its NDA for GA Depot 40mg.Benzinga Newsdesk - Mar 11, 2024, 12:29PM
- Earlier On Monday, Viatris' Mapi Pharma Received An FDA Complete Response Letter Regarding The New Drug Application For GA Depot 40mg, The Companies Are Reviewing The Content Of The CRL And Will Be Determining The Appropriate Next StepsBenzinga Newsdesk - Mar 11, 2024, 10:55AM
Wednesday, February 28, 2024
- Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday?Piero Cingari - Feb 28, 2024, 2:08PM
- Viatris shares are trading lower after the company reported worse-than-expected Q4 financial results.Benzinga Newsdesk - Feb 28, 2024, 12:33PM
- Viatris Expects Fiscal Year 2024 Adjusted EPS Of $2.70-$2.85 Versus Consensus Of $2.81Benzinga Newsdesk - Feb 28, 2024, 6:36AM
- Viatris Expects Fiscal Year 2024 Revenues Of $15.25B-$15.75B Versus Consensus Of $15.19BBenzinga Newsdesk - Feb 28, 2024, 6:35AM
- Viatris Q4 Adjusted EPS $0.62 Misses $0.65 Estimate, Sales $3.83B Miss $3.87B EstimateBenzinga Newsdesk - Feb 28, 2024, 6:33AM
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
- Viatris And Idorsia Forge Global Partnership For Breakthrough Heart Attack TreatmentsNabaparna Bhattacharya - Feb 28, 2024, 5:20AM
- Viatris And Idorsia Enter Into Significant Global Research And Development CollaborationBenzinga Newsdesk - Feb 28, 2024, 3:12AM
Monday, February 26, 2024
Tuesday, February 06, 2024
Tuesday, January 23, 2024
Monday, January 22, 2024
Friday, January 12, 2024
Wednesday, January 10, 2024
- Viatris shares are trading higher following the company's presentation at the J.P. Morgan Healthcare Conference.Benzinga Newsdesk - Jan 10, 2024, 3:49PM
- Watching Viatris; Shares Spike Higher, Co Participating At 42nd Annual J.P. Morgan Healthcare Conference Presentation Followed By A Fireside Chat Scheduled At 1:30 P.M. ETBenzinga Newsdesk - Jan 10, 2024, 2:30PM
Friday, January 05, 2024
Wednesday, January 03, 2024
Thursday, December 28, 2023
Wednesday, December 27, 2023
- Regeneron Shares Moving Higher Amid Circulation Of Court Documents Related To Patent Suit With ViatrisBenzinga Newsdesk - Dec 27, 2023, 1:49PM
- 3 Minutes To Boost Your Earnings: 3 Stocks With Over 3% Dividend Yields In Health Care Sector From Wall Street's Most Accurate AnalystsAvi Kapoor - Dec 27, 2023, 7:42AM
Monday, December 25, 2023
Saturday, December 16, 2023
Wednesday, November 22, 2023
Monday, November 13, 2023
Tuesday, November 07, 2023
- Viatris Revises Full-Year Total Revenues Guidance Range Solely To Reflect The Expected Negative Impact Of Foreign Exchange; Now Sees FY23 Revenue Down From $15.5B-$16B To $15.4B-$15.6B Vs $15.67B Est.Benzinga Newsdesk - Nov 7, 2023, 7:47PM
- Recap: Viatris Q3 EarningsBenzinga Insights - Nov 7, 2023, 4:45PM
- Viatris Q3 2023 Adj EPS $0.79 Beats $0.74 Estimate, Sales $3.94B Miss $4.02B EstimateBenzinga Newsdesk - Nov 7, 2023, 4:44PM
- Viatris Q3 Sales $3.94B Miss $4.02B EstimateBenzinga Newsdesk - Nov 7, 2023, 4:16PM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
Monday, October 30, 2023
Monday, October 23, 2023
Tuesday, October 03, 2023
- Obesity Drug Wegovy's Triumph To Bring $12B To Novo Holdings In Years Ahead: CEOVandana Singh - Oct 3, 2023, 12:17PM
- 'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top StoriesVandana Singh - Oct 3, 2023, 10:11AM